At the recent Cardiovascular and Renal Drugs Advisory Committee meeting (the "prasugrel meeting") there was much discussion over appropriate dosing in specific patient populations. It was in the midst of this confabulation that Marvin Konstam, MD (the acting chair) commented that, "We need to practice personalized medicine. We just don't know how."
Joining Dr. Konstam on the rostrum were Dr. Bob Temple and Dr. John Jenkins -- two FDAers whose job it is to help advance the practice of personalized medicine.
Yes we can.
Joining Dr. Konstam on the rostrum were Dr. Bob Temple and Dr. John Jenkins -- two FDAers whose job it is to help advance the practice of personalized medicine.
Yes we can.
